Dr Krishna Ella

Hillchol has demonstrated against both Ogawa and Inaba serotypes, and aims to address the global shortage of cholera vaccines

The UW-Madison Global One Health Center will focus on developing and producing novel vaccines in India

iNNCOVACC is the world’s first intra-nasal COVID-19 vaccine to receive approval for the primary two-dose schedule, and as a…

He was speaking to reporters on the sidelines of the 72nd Indian Pharmaceutical Conference (IPC)

Subjects were evaluated for safety, neutralising antibody responses against variants of concern, binding antibodies against spike…

The Lancet peer-review confirms the efficacy analysis which demonstrates Covaxin to be effective against COVID-19

Covaxin, the company's home-grown COVID-19 vaccine approved for emergency use in India, is one of two shots driving the country's…

The company has already deployed multiple production lines at its Hyderabad, Malur, Bengaluru and Pune campuses, and the addition…

He also said that Bharat Biotech's facility in Hyderabad can produce one crore doses of COVID vaccine a month

Led by Dr Maksym Stepanov, Minister of Health, Ukraine, the delegation also included Igor Ivashchenko, Deputy Minister of Health,…